A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis.
about
Recent advances in managing chronic HCV infection: focus on therapy in patients with severe liver diseaseThe changing landscape of hepatitis C virus therapy: focus on interferon-free treatmentHepatocellular Carcinoma in Patients with a Sustained Response to Anti-Hepatitis C TherapyHepatitis C cirrhosis: New perspectives for diagnosis and treatmentTreatment of hepatitis C in liver transplant patients: interferon out, direct antiviral combos inNew Concepts on Pathogenesis and Diagnosis of Liver Fibrosis; A Review ArticleOxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesisStrategies and endpoints of antifibrotic drug trials: Summary and recommendations from the AASLD Emerging Trends Conference, Chicago, June 2014.Interferon-free combination therapies for the treatment of hepatitis C: current insightsFuture of liver disease in the era of direct acting antivirals for the treatment of hepatitis CThe impact of the revolution in hepatitis C treatment on hepatocellular carcinoma.Virologic Cure of Hepatitis C: Impact on Hepatic Fibrosis and Patient Outcomes.Changes of shear-wave velocity by interferon-based therapy in chronic hepatitis C.Noninvasive diagnosis of cirrhosis: a review of different imaging modalities.Identifying nonalcoholic fatty liver disease patients with active fibrosis by measuring extracellular matrix remodeling rates in tissue and blood.Frontiers in the treatment of hepatitis C virus infection.Epithelial VEGF signaling is required in the mouse liver for proper sinusoid endothelial cell identity and hepatocyte zonation in vivoReversal, maintenance or progression: what happens to the liver after a virologic cure of hepatitis C?The association of IL28B genotype with the histological features of chronic hepatitis C is HCV genotype dependent.Image analysis of liver collagen using sirius red is more accurate and correlates better with serum fibrosis markers than trichrome.Future therapy of portal hypertension in liver cirrhosis - a guess.Pathobiology of liver fibrosis: a translational success storySerological Tests Do Not Predict Residual Fibrosis in Hepatitis C Cirrhotics with a Sustained Virological Response to Interferon.Ongoing liver inflammation in patients with chronic hepatitis C and sustained virological responseSuccessful Interferon Therapy Reverses Enhanced Hepatic Progenitor Cell Activation in Patients with Chronic Hepatitis CSustained virological response: a milestone in the treatment of chronic hepatitis C.Cirrhosis and rapid virological response to peginterferon plus ribavirin determine treatment outcome in HCV-1 IL28B rs12979860 CC patients.Liver Stiffness Decreases Rapidly in Response to Successful Hepatitis C Treatment and Then PlateausAltered quality of life in the early stages of chronic hepatitis C is due to the virus itselfCost-effectiveness of Early Treatment of Hepatitis C Virus Genotype 1 by Stage of Liver Fibrosis in a US Treatment-Naive Population.A Cost-Utility Analysis of Different Antiviral Medicine Regimens in Patients With Chronic Hepatitis C Virus Genotype 1 Infection.PegIFN-α2a for the treatment of chronic hepatitis B and C: a 10-year history.Management of HCV patients with cirrhosis with direct acting antivirals.Hepatitis C-related liver cirrhosis - strategies for the prevention of hepatic decompensation, hepatocarcinogenesis, and mortalityCirrhosis regression in hepatitis C patients with sustained virological response after antiviral therapy: a meta-analysis.Future treatments of cirrhosis.The past 10 years of gastroenterology and hepatology-reflections and predictions.Achieving sustained virological response: what's the impact on further hepatitis C virus-related disease?Sorting out cirrhosis: mechanisms of non-response to hepatitis C therapy.A pleasant dilemma to have: to treat the HCV patient on the waiting list or to treat post-liver transplantation?
P2860
Q26752433-57BB4068-32D4-456F-9CB1-A1A05838D49BQ26795559-616454E7-0018-4484-BB45-1DB163378766Q26795750-6F5D5722-AA94-44A8-BD5B-03FA9F8D56A5Q26799924-024F765E-E53B-4EF5-9FBC-DE309909CB60Q26820811-F4A2D82A-2596-418B-846D-55C5D15AA45FQ28070168-8B7B90B4-2ACF-4F8C-BB1A-D1414C6CFECEQ28075646-3021D71E-B451-4090-8721-4619EE94AEE2Q28082065-BAB749E9-A7AE-44DD-BD1A-56185249F06EQ28087400-EC31E689-731F-42F6-8B77-25B26A3374F1Q30235178-292981D2-9F8F-4A92-AB1E-6F6F51585EF6Q30250096-4B1CD2A7-514B-4A6D-A869-24513E5F0215Q30250322-199F1071-3EA0-49E7-B8DF-70D9FF0D4898Q30402571-0B0DC01B-4A7C-4017-AE65-8B1F077182EBQ30436164-FB8A48B5-B9E3-4892-9C71-1704A2C6EBC4Q31134971-9BE5128A-821C-4334-983F-FB72A180D8EBQ33571517-EEFA76F9-B53F-4FE2-840D-2FD6BF69925EQ33626588-4088376B-493A-4EE1-B1E5-F814BE2F9F29Q33731308-B4CCF3BF-0687-41D4-96CC-91B4353B69A1Q33755525-0A103FDB-7DDB-4132-8F4A-6ECECD8F5501Q34036477-E164F2EE-3416-49BF-B13A-FDB5BEE3B247Q34446521-84A47969-9BC1-439E-AF53-E94C98186784Q34462733-1EC6FA02-D217-4B1F-95FD-158EC9AB9D3BQ36052963-FF8BC399-AF6C-423E-986D-1863029D679CQ36280109-4E48442E-8D71-4A01-8E2D-D33BFF95227DQ36382849-D653F046-05D7-4C02-AF9A-073D6A1B4EAEQ36841325-035F0D42-6B91-438C-BB62-C1DA0721DA1FQ37044222-D4F97C97-53A0-4404-945B-2637435854E8Q37115469-2D4DD837-6BC9-4566-A9D4-51D403AFA346Q37333822-49537831-1119-4DEB-8955-DABDFF41D5E1Q37484155-D165C37B-26ED-4696-A1AC-3C0C0FBF9454Q37629097-502A0240-7532-4C48-B3F9-63F36958B7FEQ38102776-0DFEC074-A8C2-4E9A-A09E-E39D3688A3B9Q38174248-8048A2CD-C22F-42F8-B17F-C2CD9516C602Q38198618-58B18ED0-589F-4CED-B0BA-1C4FEFC7752BQ38207083-CE7CD908-82AC-4CEA-A0B0-0CFDFD7711AEQ38218607-4F034D51-DCDE-4D8B-8F72-5B533FB86689Q38257761-359A60E8-0520-4521-85A7-A93F4A12F82DQ38314738-24A5E078-C827-406D-9CF7-77C8C30EB5C1Q38458110-63408372-5AF0-402B-BA82-C2281AB3CF07Q38578520-FF17AC1D-0791-4037-9B94-90BC6E0D10C2
P2860
A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
A morphometric and immunohisto ...... virus patients with cirrhosis.
@en
A morphometric and immunohisto ...... virus patients with cirrhosis.
@nl
type
label
A morphometric and immunohisto ...... virus patients with cirrhosis.
@en
A morphometric and immunohisto ...... virus patients with cirrhosis.
@nl
prefLabel
A morphometric and immunohisto ...... virus patients with cirrhosis.
@en
A morphometric and immunohisto ...... virus patients with cirrhosis.
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
A morphometric and immunohisto ...... virus patients with cirrhosis.
@en
P2093
Guido Ronchi
Maria Francesca Donato
Maria Grazia Rumi
Massimo Colombo
P2860
P304
P356
10.1002/HEP.25606
P407
P577
2012-07-02T00:00:00Z